dc.contributor.author | Plaza Teixeira, Roberto Augusto | |
dc.contributor.author | Odone-Filho, Vicente | |
dc.contributor.author | Camargo, Beatriz de | |
dc.contributor.author | Zerbini, Maria Claudia | |
dc.contributor.author | Fillipi, Renne | |
dc.contributor.author | Alencar, Arlaine | |
dc.contributor.author | Cristofani, Lilian | |
dc.date.accessioned | 2016-01-24T14:06:24Z | |
dc.date.available | 2016-01-24T14:06:24Z | |
dc.date.issued | 2011-04-01 | |
dc.identifier | http://dx.doi.org/10.3109/08880018.2010.533250 | |
dc.identifier.citation | Pediatric Hematology and Oncology. London: Informa Healthcare, v. 28, n. 3, p. 194-202, 2011. | |
dc.identifier.issn | 0888-0018 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/33629 | |
dc.description.abstract | Fifteen percent of patients with Wilms'' tumor (WT) experience relapse. It has been suggested that weight and age may affect the chances of relapse. Few studies have investigated the role, if any, between P-glycoprotein (P-gp) and relapse. the authors assessed the prognostic value of tumor weight and age at diagnosis and asked whether some other potential biological markers, specifically P-gp protein expression, had a prognostic value in favorable-histology WT. No association between age and relapse could be found. Patients with tumor weight >= a parts per thousand yen550 g were 6 times more likely to relapse, whereas P-gp expression was positive in 18/40 (45%%) of the patients, of which 10/12 (83.3%%) relapsed and 8/28 (28.6%%) did not. Further studies are necessary to elucidate whether or not P-gp is related to relapse in patients with histologically favorable Wilms'' tumor. If confirmed, the protein may be used in the future as a target for new drugs and treatments for this group of patients.</. | en |
dc.format.extent | 194-202 | |
dc.language.iso | eng | |
dc.publisher | Informa Healthcare | |
dc.relation.ispartof | Pediatric Hematology and Oncology | |
dc.rights | Acesso restrito | |
dc.subject | P-glycoprotein | en |
dc.subject | prognosis | en |
dc.subject | recurrence | en |
dc.subject | tumor weight | en |
dc.subject | Wilms' tumor | en |
dc.title | P-Glycoprotein Expression, Tumor Weight, Age, and Relapse in Patients with Stage I and II Favorable-Histology Wilms' Tumor | en |
dc.type | Artigo | |
dc.rights.license | http://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.description.affiliation | HC FMUSP, Inst Crianca, Dept Pediat Oncol & Hematol, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Inst Crianca, Dept Pediat Oncol & Hematol, Hosp Clin,Fac Med, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Dept Stat, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Fac Med, Dept Pathol, São Paulo, Brazil | |
dc.description.affiliation | Hosp Canc AC Camargo, Dept Pediat, São Paulo, Brazil | |
dc.identifier.doi | 10.3109/08880018.2010.533250 | |
dc.description.source | Web of Science | |
dc.identifier.wos | WOS:000288076400004 | |